Sequential Intravenous Plus Intra-arterial Chemotherapy versus Intra-arterial Chemotherapy in Children with Advanced Unilateral Retinoblastoma
Ophthalmology and Therapy · 17.11.2026
DOI: 10.1007/s40123-026-01534-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology and Therapy, online erschienen am 17.11.2026. Verfasst von Xuyang Wen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhi Zao Ju Road, Shanghai, 200011, Ch…. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Clinical Research Plan of Shanghai Hospital Development Center, National Natural Science Foundation of China.
Themen: Onkologische Pflege, Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Retinoblastoma is the most common primary intraocular malignancy in children. Intra-arterial chemotherapy improves local drug delivery and globe salvage, but repeated catheterization may damage ocular vessels. Intravenous chemotherapy (IVC) may cause systemic toxicity. This trial will test whether two initial intravenous cycles followed by two intra-arterial cycles preserve efficacy while reducing the burden of each treatment route.
Methods
We will enroll 288 untreated children aged > 3 months and weighing > 5 kg with unilateral American Joint Committee on Cancer (AJCC) cT2N0M0 retinoblastoma in this multicenter, open-label, assessor-masked, randomized noninferiority trial. A central interactive web response system will assign participants 1:1 using variable block randomization stratified by center and cT2a/cT2b stage. The experimental group will receive two cycles of IVC followed by two cycles of intra-arterial chemotherapy (IAC). The control group will receive four cycles of IAC. Focal therapy is permitted. The primary outcome is 2-year progression-free globe salvage assessed over 24 months. Planned Outcomes The trial will evaluate whether sequential intravenous plus intra-arterial chemotherapy provides acceptable tumor control while limiting treatment-related harm and resource use in unilateral cT2 disease. The primary outcome is the 2-year progression-free globe salvage rate. Secondary outcomes are 2-year globe salvage, objective response, all-cause mortality, recurrence, intracranial metastasis, local and systemic toxicity, retention of measurable vision, and treatment cost. Trial Registration Chinese Clinical Trial Registry, ChiCTR2000036586; prospectively registered on 24 August 2020.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhi Zao Ju Road, Shanghai, 200011, China.
- State Key Laboratory of Eye Health, Shanghai, China.
- Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China.
- Institute of Clinical Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Ophthalmology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
- Department of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Förderung
- Clinical Research Plan of Shanghai Hospital Development Center
- National Natural Science Foundation of China
Zitieren
APA
Wen, X., Shi, H., Han, M., Chai, P., Mu, R., Yu, Z., Yang, C., Ji, X., Fan, J., Jia, R., & Fan, X. (2026). Sequential Intravenous Plus Intra-arterial Chemotherapy versus Intra-arterial Chemotherapy in Children with Advanced Unilateral Retinoblastoma. Ophthalmology and Therapy. https://doi.org/10.1007/s40123-026-01534-7
Vancouver
Wen X, Shi H, Han M, Chai P, Mu R, Yu Z, et al. Sequential Intravenous Plus Intra-arterial Chemotherapy versus Intra-arterial Chemotherapy in Children with Advanced Unilateral Retinoblastoma. Ophthalmology and Therapy. 2026. doi:10.1007/s40123-026-01534-7
BibTeX
@article{Wen2026,
author = {Wen, Xuyang and Shi, Huanxiao and Han, Minglei and Chai, Peiwei and Mu, Rongji and Yu, Zhangsheng and Yang, Chenhao and Ji, Xunda and Fan, Jiayan and Jia, Renbing and Fan, Xianqun},
title = {Sequential Intravenous Plus Intra-arterial Chemotherapy versus Intra-arterial Chemotherapy in Children with Advanced Unilateral Retinoblastoma},
journal = {Ophthalmology and Therapy},
year = {2026},
doi = {10.1007/s40123-026-01534-7}
}
EUVIMED